Home
Conditions
Urologic Neoplasms

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

2,952 public trials 631 recruiting studies

Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Active, Not Recruiting

Intravesical Adoptive Cell Therapy w/ TIL for BCG Exposed High Grade NMIBC

NCT05768347

Conditions: Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +14 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

View Trial Details

Active, Not Recruiting

Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid Tumors

NCT02869217

Conditions: Adnexal Diseases, Bladder Cancer, Digestive System Diseases, +52 more
Locations: Princess Margaret Cancer Centre Toronto, Ontario, Canada

View Trial Details

Active, Not Recruiting

Treating Muscle-invasive Bladder Cancer With A Non-surgical Method Consisting of Anti-PD-1 Therapy and Chemoradiation

NCT05975307

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +11 more
Locations: Cancer Center, Sun Yat-sen University Guangzhou, Guangdong, China

View Trial Details

Active, Not Recruiting

Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer.

NCT03983954

Conditions: Adenocarcinoma, Adenocarcinoma Of Esophagus, Adenoma, +79 more
Locations: Shalby Hospital Ahmedabad, Gujarat, India

National Cancer Institute Jhajjar, Haryana, India

All India Institute of Medical Sciences New Delhi, India

PMCH (Pacific Medical College & Hospital) Udaipur, Rajasthan, India

View Trial Details

Active, Not Recruiting

The Role of Universal Cancer Only Marker SIX6 in Diagnosing Non-Muscle Invasive Bladder Cancer

NCT07252297

Conditions: Carcinoma, Disease, Female Urogenital Diseases, +16 more
Locations: Xi Jing Hopspital Xi'an, ShannxI, China

View Trial Details

Active, Not Recruiting

Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in Urologic Surgery (Expand URO)

NCT05696444

Conditions: Adenocarcinoma, Bladder Cancer, Carcinoma, +40 more
Locations: City of Hope Duarte, California, United States

University of Chiago Chicago, Illinois, United States

Mount Sinai New York, United States

Duke Medical Center Durham, North Carolina, United States

View Trial Details

Active, Not Recruiting

A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors

NCT05238883

Conditions: Adenocarcinoma, Adenoma, Bronchial Neoplasms, +57 more
Locations: Mayo Clinic Scottsdale, Arizona, United States

USC/Norris Comprehensive Cancer Center Los Angeles, California, United States

Mayo Clinic Jacksonville, Florida, United States

Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Active, Not Recruiting

EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults

NCT03618381

Conditions: Carcinoma, Clear Cell Sarcoma, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +60 more
Locations: Seattle Children's Hospital Seattle, Washington, United States

View Trial Details

Active, Not Recruiting

(CLONEVO): Cell cycLe inhbitiON to Target the EVolution of UrOthelial Cancer

NCT03837821

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Weill Cornell Medicine New York, United States

UT Southwestern Medical Center - Simmons Comprehensive Cancer Center Dallas, Texas, United States

View Trial Details

Active, Not Recruiting

Atezolizumab After Chemo-radiotherapy for MIBC Patients Not Eligible for Radical Cystectomy

NCT03697850

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Institut Bergonie Bordeaux, France

Centre Jean Perrin Clermont-Ferrand, France

Centre Georges Francois Leclerc Dijon, France

Centre Oscar Lambret Lille, France

View Trial Details

Urologic Neoplasms

Urologic Neoplasms trial results

Related conditions